![](/img/cover-not-exists.png)
PMU101 MOST BOTHERSOME SYMPTOM MEASUREMENT STRATEGIES: CONSIDERATIONS FOR REGULATED CLINICAL TRIALS
Mazar, I., Ollis, S., Li, S., Yaworsky, A., Gwaltney, C.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1262
Date:
May, 2019
File:
PDF, 319 KB
2019